Guilin Pavay Biotechnology Co., Ltd. was founded in October 2015 and is a technology-based enterprise specializing in the research and production of products such as epidermal growth factor and sodium hyaluronate. As a professional manufacturer of medical beauty products, Warnover has multiple production lines, including pre filled syringe filling production line, aluminum tube filling production line, plastic bottle filling production line, and a batch of advanced production and testing equipment. In the process of years of enterprise development, the company has established a mature medical beauty market channel.

Hairui Pharmaceutical is a modern comprehensive pharmaceutical enterprise integrating R&D, production and marketing. It is located in Science City, Guangzhou High-tech Industrial Development Zone. It currently has 2 drug research institutes, 4 modern production workshops and 1 Automated high-bay warehouse.

Shenzhen Xinguang United Pharmaceutical Co., Ltd. mainly engages in the production of Banlangen tea, production of Hantao leaves, production of Xiasangju granules and other products. The company respects the corporate spirit of "down-to-earth, hard work, and responsibility", and with integrity, win-win, and innovative business philosophy, creates a good corporate environment. With a new management model, perfect technology, thoughtful service, and excellent quality as the foundation of survival, we always adhere to the principle of putting customers first and serving them wholeheartedly, and insist on using our own services to impress customers.

Shenzhen Tianneng Pharmaceutical Co., Ltd. is located in the Tianneng Science and Technology Park in Pingdi Street, Longgang District, Shenzhen, with beautiful scenery, pleasant climate, lush trees, and convenient transportation; Having a spacious, bright, and tidy garden style factory, covering an area of 12000 square meters, including a building area of 17000 square meters, the environment is beautiful, and it is a teaching, research, and internship base for medical universities. Currently, the industrial scale is constantly expanding.

Jiangxi Longlai Biopharmaceutical Co., Ltd. was founded in 2009 by Dr. Wu Shengwen, a renowned overseas expert who returned to China. It was completed in 2011 and merged with the American company Kairuist (Suzhou) Biochemical Co., Ltd. at the end of 2012. Currently, Dr. Wu Shengwen serves as the President of the merged new company and also serves as the Chairman and General Manager of Longlai Company. The company is led by internationally renowned investment bank Kaipeng Huaying from the United States, with other investors including Israel, Hong Kong, Japan, Suzhou, and Jiangxi Venture Capital. The company invested 100 million yuan in personnel in the early stage

Zhongke Hongji Biotechnology Co., Ltd. was established on April 14, 2010, with a registered capital of RMB 500 million. Its business scope is the research, development, and sales of biotechnology products. The company's construction adheres to the requirements of industrialization, agglomeration, and international development, adhering to the combination of expanding industrial scale and enhancing independent innovation capabilities, in order to accelerate the development of industries such as biopharmaceuticals, bio based chemicals, biomaterials, biological manufacturing, and biological environmental protection.